Switch theme
Sign up to access all valuation multiples
Monivent AB is a medtech company focused on improving the care given to newborn babies in need of respiratory support at birth. The company has developed a patented solution that provides continuous feedback on the volumes of air given to the newborn during manual ventilation. The airflow is measured directly in the face mask and feedback on the ventilation parameters is displayed numerically and graphically in real-time on the external monitor. The company's product is Monivent Neo100.
2013
n/a
Last FY Revenue $0.2M
Last FY EBITDA -$1.1M
$1.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Monivent achieved revenue of $0.2M and an EBITDA of -$1.1M.
Monivent expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Monivent valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $0.2M | XXX | XXX | XXX |
| Gross Profit | XXX | $0.2M | XXX | XXX | XXX |
| Gross Margin | XXX | 90% | XXX | XXX | XXX |
| EBITDA | XXX | -$1.1M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -485% | XXX | XXX | XXX |
| EBIT | XXX | -$1.2M | XXX | XXX | XXX |
| EBIT Margin | XXX | -522% | XXX | XXX | XXX |
| Net Profit | XXX | -$1.2M | XXX | XXX | XXX |
| Net Margin | XXX | -545% | XXX | XXX | XXX |
| Net Debt | XXX | $0.1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Monivent's stock price is SEK 0 (or $0).
Monivent has current market cap of SEK 21.6M (or $2.2M), and EV of SEK 18.6M (or $1.9M).
See Monivent trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.9M | $2.2M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Monivent has market cap of $2.2M and EV of $1.9M.
Monivent's trades at 8.7x EV/Revenue multiple, and -1.8x EV/EBITDA.
Equity research analysts estimate Monivent's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Monivent's P/E ratio is not available.
See valuation multiples for Monivent and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.2M | XXX | $2.2M | XXX | XXX | XXX |
| EV (current) | $1.9M | XXX | $1.9M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 8.7x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -1.8x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -1.7x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -1.9x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -1.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMonivent's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Monivent's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Monivent's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Monivent and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -485% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 612% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Monivent acquired XXX companies to date.
Last acquisition by Monivent was XXXXXXXX, XXXXX XXXXX XXXXXX . Monivent acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Monivent founded? | Monivent was founded in 2013. |
| Where is Monivent headquartered? | Monivent is headquartered in Sweden. |
| Is Monivent publicy listed? | Yes, Monivent is a public company listed on SAT. |
| What is the stock symbol of Monivent? | Monivent trades under MONI ticker. |
| When did Monivent go public? | Monivent went public in 2020. |
| Who are competitors of Monivent? | Similar companies to Monivent include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Monivent? | Monivent's current market cap is $2.2M |
| Is Monivent profitable? | Yes, Monivent is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
